Nanobac Pharmaceuticals (EM)【NNBP】銘柄情報

Nanobac Pharmaceuticals Inc (EM) (NNBP) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.000001

( - )

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

0.000001 52 週間の範囲 0.000001

時価総額

249.507

前日終値

0.000001

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 1,000

発行済株式数

249,506,760

配当利回り

PER

-0

1 株当たり利益 (EPS)

-0.03

歳入

17.62k

純利益

-6.58M

Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. ... Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company’s diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases, as well as cardiovascular diseases. Nanobac Pharmaceuticals, Incorporated was formerly known as HealthCentrics Inc. and changed its name to Nanobac Pharmaceuticals, Incorporated in December 2002. The company was founded in 1994 and is based in Tampa, Florida. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

本社

Tampa, United States

設立

1994

Nanobac Pharmaceuticals Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker NNBP. The last closing price for Nanobac Pharmaceuticals (EM) was US$0. Over the last year, Nanobac Pharmaceuticals (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.000001.

Nanobac Pharmaceuticals (EM) currently has 249,506,760 shares in issue. The market capitalisation of Nanobac Pharmaceuticals (EM) is US$249.51 . Nanobac Pharmaceuticals (EM) has a price to earnings ratio (PE ratio) of -0.00.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	1.0E-6	1.0E-6	1.0E-6	1000	1.0E-6	CS
12	0	0	1.0E-6	1.0E-6	1.0E-6	250	1.0E-6	CS
26	0	0	1.0E-6	1.0E-6	1.0E-6	33608	1.0E-6	CS
52	0	0	1.0E-6	1.0E-6	1.0E-6	80134	1.0E-6	CS
156	0	0	1.0E-6	1.0E-6	1.0E-6	60678	1.0E-6	CS
260	-0.000199	-99.5	0.0002	0.00065	1.0E-6	102999	0.00012812	CS

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Nanobac Pharmaceuticals Inc (EM) (NNBP)

Nanobac Pharmaceuticals Inc (EM) (NNBP) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

Nanobac Pharmaceuticals Inc (EM) について

NNBP 最新ニュース

Nanobac Pharmaceuticals Merger Partner, Eureka Genomics, and Glycos Biotechnologies Work Together to Sequence Proprietary Bacter

Nanobac Pharmaceuticals Merger Partner Eureka to Utilize Best-In-Class Illumina Genome Analyzer Technology at Newly Launched Eur

Nanobac Pharmaceuticals and Eureka Genomics Sign Merger Agreement

Nanobac Pharmaceuticals and Eureka Genomics Agree to Terms for Merger

Nanobac Message to Shareholders

Nanobac Announces Peer Reviewed Publication Verifying Self-Propagating Calcifying Nanoparticles as a Unique Entity

Nanobac Announces Mayo Clinic Researchers Audio Interview

Nanobac Pharmaceuticals, Inc. Announces Collaboration Agreement With BioChemics for Transdermal Therapeutic Formulation

Nanobac Announces Study Results of Association of Nanoparticle and Kidney Stone Formation

Nanobac Announces Publication of Association of Nanoparticle and Kidney Stone Formation

NNBP - Frequently Asked Questions (FAQ)

NNBP 取引

NNBP Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する